Literature DB >> 12071542

Gender and obstructive sleep apnea syndrome, part 1: Clinical features.

Fotis Kapsimalis1, Meir H Kryger.   

Abstract

In the two decades after obstructive sleep apnea syndrome (OSAS) was described, it was considered a disease primarily of males. As a result, for many years, epidemiologic studies of the general population examining the prevalence of OSAS included only males and investigators examined almost exclusively males in their pathophysiologic studies. It has been widely recognized that OSAS in women is not as rare as it was originally believed. Whereas early studies of clinic populations suggested that females made up about 10% or less of OSAS cases, later studies of the general population suggest that about a third of all cases are females. This suggests that there may be clinical under-recognition of OSAS in females. We explore the reasons for the male predominance of OSAS, and the clinical under-recognition in females by examining differences in clinical presentation and polysomnography findings between male and female patients.

Entities:  

Mesh:

Year:  2002        PMID: 12071542

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  43 in total

1.  Testosterone restores respiratory long term facilitation in old male rats by an aromatase-dependent mechanism.

Authors:  N R Nelson; I M Bird; M Behan
Journal:  J Physiol       Date:  2010-11-15       Impact factor: 5.182

Review 2.  Sex steroidal hormones and respiratory control.

Authors:  Mary Behan; Julie M Wenninger
Journal:  Respir Physiol Neurobiol       Date:  2008-12-10       Impact factor: 1.931

3.  Study of a Novel APAP Algorithm for the Treatment of Obstructive Sleep Apnea in Women.

Authors:  Nigel McArdle; Stuart King; Kelly Shepherd; Vanessa Baker; Dinesh Ramanan; Sahisha Ketheeswaran; Peter Bateman; Alison Wimms; Jeff Armitstead; Glenn Richards; David Hillman; Peter Eastwood
Journal:  Sleep       Date:  2015-11-01       Impact factor: 5.849

4.  Cost-effectiveness of CPAP treatment related to cardiovascular disease in patients with severe OSAS: the Greek experience.

Authors:  Charalampos Mermigkis; Izolde Bouloukaki; Sophia E Schiza
Journal:  Sleep Breath       Date:  2014-10-11       Impact factor: 2.816

5.  Diagnosis and initiation of nasal continuous positive airway pressure therapy for OSAS without a preceding sleep study?

Authors:  Ulla Anttalainen; Kari Liippo; Tarja Saaresranta
Journal:  Sleep Breath       Date:  2010-12-01       Impact factor: 2.816

6.  Estrogen-mimicking isoflavone genistein prevents bone loss in a rat model of obstructive sleep apnea-hypopnea syndrome.

Authors:  Lige Song; Xiao Liang; Yun Zhou
Journal:  Int J Clin Exp Pathol       Date:  2014-03-15

7.  Sleep breathing disorders in the U.S. female population.

Authors:  Fotis Kapsimalis; Meir Kryger
Journal:  J Womens Health (Larchmt)       Date:  2009-08       Impact factor: 2.681

8.  Sex differences in white matter alterations accompanying obstructive sleep apnea.

Authors:  Paul M Macey; Rajesh Kumar; Frisca L Yan-Go; Mary A Woo; Ronald M Harper
Journal:  Sleep       Date:  2012-12-01       Impact factor: 5.849

9.  The impact of gender on timeliness of narcolepsy diagnosis.

Authors:  Christine Won; Mandana Mahmoudi; Li Qin; Taylor Purvis; Aditi Mathur; Vahid Mohsenin
Journal:  J Clin Sleep Med       Date:  2014-01-15       Impact factor: 4.062

Review 10.  Severe upper airway obstruction during sleep.

Authors:  H William Bonekat; Kimberly A Hardin
Journal:  Clin Rev Allergy Immunol       Date:  2003-10       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.